As a clinical pharmacist, you will see more focus on managing nonalcoholic fatty liver disease (NAFLD) , partly due to new guidelines. It’s being called a “sleeper epidemic” About 1 in 4 patients have this steatosis, but most don’t have symptoms. NAFLD often goes hand in hand with cardiovascular (CV) risk factors, such as insulin resistance or diabetes , obesity an…
Read morePatients are asking THE PHARMACIST if vitamin E supplements are dangerous. Many people take vitamin E in hopes of preventing cardiovascular disease, dementia, etc. Vitamin E is a lipid soluble antioxidant best known for its ability to inhibit lipid peroxidation by scavenging reactive oxygen species and to preserve cell membranes. Now an analysis suggests that HIGH-…
Read moreN onalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world. Severity ranges from mild disease with steatosis (buildup of fat in the liver) to more severe disease with inflammation and hepatocyte (liver cell) injury known as nonalcoholic steatohepatitis (NASH). NASH is projected to be the leading liver transplant indication by the …
Read moreNPS | Notes in Pharmacy Specialties is a free, open-access, peer-reviewed site focused on pharmacy practice. Articles are immediately accessible, covering clinical pharmacy, pharmaceutical care, health promotion, informatics, and more.
Egypt - Phone: (+20)1210274589
Gmail: abdelwahabward@gmail.com
Social Plugin